Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mebendazole for the Treatment of Pediatric Gliomas
NCT01837862Phase 2Active, not recruiting
- Sponsor
- Krystal Biotech, Inc.
- Start
- Oct 2013
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mebendazole in glioma, sponsored by Krystal Biotech, Inc.. Started Oct 2013; status: active, not recruiting.
02
Drugs
mebendazole
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01837862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01837862.